These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8628876

  • 1. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
    van Dijke CF, Brasch RC, Roberts TP, Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P, Schwickert HC.
    Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
    Schwickert HC, Stiskal M, Roberts TP, van Dijke CF, Mann J, Mühler A, Shames DM, Demsar F, Disston A, Brasch RC.
    Radiology; 1996 Mar; 198(3):893-8. PubMed ID: 8628889
    [Abstract] [Full Text] [Related]

  • 3. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC.
    AJR Am J Roentgenol; 1998 Oct; 171(4):941-9. PubMed ID: 9762973
    [Abstract] [Full Text] [Related]

  • 4. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM, Kuwatsuru R, Shames DM, Neuder M, Mann JS, Vexler V, Rosenau W, Brasch RC.
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [Abstract] [Full Text] [Related]

  • 5. Arthritic temporomandibular joint: correlation of macromolecular contrast-enhanced MR imaging parameters and histopathologic findings.
    van Dijke CF, Kirk BA, Peterfy CG, Genant HK, Brasch RC, Kapila S.
    Radiology; 1997 Sep; 204(3):825-32. PubMed ID: 9280267
    [Abstract] [Full Text] [Related]

  • 6. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas.
    Brasch RC, Shames DM, Cohen FM, Kuwatsuru R, Neuder M, Mann JS, Vexler V, Mühler A, Rosenau W.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S8-11. PubMed ID: 7928277
    [No Abstract] [Full Text] [Related]

  • 7. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S.
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [Abstract] [Full Text] [Related]

  • 8. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media.
    Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC.
    Pediatr Radiol; 1998 Feb; 28(2):67-78. PubMed ID: 9472047
    [Abstract] [Full Text] [Related]

  • 9. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
    Harika L, Weissleder R, Poss K, Papisov MI.
    Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
    [Abstract] [Full Text] [Related]

  • 10. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.
    Turetschek K, Huber S, Floyd E, Helbich T, Roberts TP, Shames DM, Tarlo KS, Wendland MF, Brasch RC.
    Radiology; 2001 Feb; 218(2):562-9. PubMed ID: 11161179
    [Abstract] [Full Text] [Related]

  • 11. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N, Marzola P, Boschi F, Sbarbati A, D'Onofrio M, Pozzi Mucelli R.
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [Abstract] [Full Text] [Related]

  • 12. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium.
    Brasch RC, Schwickert HC, Roberts TP, Shames DM, van Dijke CF, Mann JS, Demsar F.
    Acad Radiol; 1996 Aug; 3 Suppl 2():S464-5. PubMed ID: 8796630
    [No Abstract] [Full Text] [Related]

  • 13. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.
    Gossmann A, Okuhata Y, Shames DM, Helbich TH, Roberts TP, Wendland MF, Huber S, Brasch RC.
    Radiology; 1999 Oct; 213(1):265-72. PubMed ID: 10540670
    [Abstract] [Full Text] [Related]

  • 14. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R.
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging.
    Vogl TJ, Pegios W, Mack MG, Hünerbein M, Hintze R, Adler A, Lobbeck H, Hammerstingl R, Wust P, Schlag P, Felix R.
    AJR Am J Roentgenol; 1997 Jun; 168(6):1427-34. PubMed ID: 9168702
    [Abstract] [Full Text] [Related]

  • 16. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
    Nakahara H, Noguchi S, Murakami N, Tamura S, Jinnouchi S, Kodama T, Adjei ON, Nagamachi S, Ohnishi T, Futami S, Flores LG, Watanabe K.
    Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
    [Abstract] [Full Text] [Related]

  • 17. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution.
    Demsar F, Roberts TP, Schwickert HC, Shames DM, van Dijke CF, Mann JS, Saeed M, Brasch RC.
    Magn Reson Med; 1997 Feb; 37(2):236-42. PubMed ID: 9001148
    [Abstract] [Full Text] [Related]

  • 18. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
    Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP.
    Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
    [Abstract] [Full Text] [Related]

  • 19. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
    Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Schaeffer U, Brix G, Essig M, Hoffmann U, Zuna I, Schönberg S, van Kaick G.
    Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
    [Abstract] [Full Text] [Related]

  • 20. Spatial mapping of microvascular permeability and tissue blood volume using magnetic resonance imaging.
    Demsar F, Roberts TP, Schwickert HC, Shames DM, van Dijke CF, Mann JS, Saeed M, Brasch RC.
    Acad Radiol; 1996 Aug; 3 Suppl 2():S344-6. PubMed ID: 8796599
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.